Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivos Therapeutics

3.47
+0.430014.14%
Volume:1.16M
Turnover:4.25M
Market Cap:20.44M
PE:-2.04
High:3.89
Open:3.54
Low:3.40
Close:3.04
Loading ...

Vivos Therapeutics to Acquire The Sleep Center of Nevada

MT Newswires Live
·
16 Apr

BRIEF-Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada

Reuters
·
16 Apr

Vivos Therapeutics announces agreement to acquire operating assets of SCN

TIPRANKS
·
16 Apr

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
15 Apr

Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ...

GuruFocus.com
·
03 Apr

Vivos Therapeutics’ Earnings Call Highlights Growth and Expansion

TIPRANKS
·
02 Apr

Vivos Therapeutics Reports Revenue Growth and Strategic Shift

TIPRANKS
·
01 Apr

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
01 Apr

Vivos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Vivos Therapeutics FY 2024 GAAP EPS $(2.22) Beats $(2.25) Estimate, Sales $15.000M Miss $15.202M Estimate

Benzinga
·
01 Apr

Press Release: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Dow Jones
·
01 Apr

Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
29 Mar

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

GlobeNewswire
·
28 Mar

Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
24 Mar

Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide

GlobeNewswire
·
24 Feb

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.

GlobeNewswire
·
18 Feb

Investors Give Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares A 30% Hiding

Simply Wall St.
·
16 Feb

BRIEF-Vivos Therapeutics Inc Files For Mixed Shelf Of Up To $50 Million – SEC Filing

Reuters
·
12 Feb

Vivos Therapeutics Inc Files for Mixed Shelf of up to $50 Mln – SEC Filing

THOMSON REUTERS
·
12 Feb

Vivos Therapeutics files to sell 854,332 shares of common stock for holders

TIPRANKS
·
22 Jan